Sat.Sep 17, 2022

WHO calls for urgent action by countries for achieving Medication Without Harm

The Pharma Data

Encyclopedically, half of all preventable detriment in medical care is drug related, a quarter of which is severe or life- hanging. In the lead up to World Patient Safety Day on 17 September 2022, WHO is emphasizing the global burden of drug detriment.

Drugs 72

Which pharma companies have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…. The post Which pharma companies have the most supplementary protection certificates?

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Pfizer and BioNTech Admit Positive CHMP Opinion for Conversion of COMIRNATY ® tentative Marketing Authorization to Full Marketing Authorization in the European Union

The Pharma Data

Standard marketing authorization recommendation applies to all suggestions and phrasings in the European Union, including COMIRNATY ® Original/ OmicronBA.4- 5 and COMIRNATY ® Original/ OmicronBA.1

CHMP recommends approval of Beyfortus® (nirsevimab) for prevention of RSV disease in infants

The Pharma Data

CHMP recommends blessing of Beyfortus ®( nirsevimab) for forestallment of RSV complaint in babies. Recommendation is grounded on the Beyfortus clinical trial program which demonstrated protection against medically attended lower respiratory tract infection caused by RSV with a single cure during the RSV season Still, Beyfortus would be the first astronomically defensive option for babe and babies If approved.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children

The Pharma Data